Floege J, et al. - The efficacy, as well as tolerability of sucroferric oxyhydroxide and sevelamer in the peritoneal dialysis (PD) patient population, were investigated in this subanalysis. In this patient population, sucroferric oxyhydroxide afforded a relatively low pill burden and a high rate of adherence but was noninferior to sevelamer for controlling serum phosphorus.